Health and Human Services Secretary Robert F. Kennedy Jr. has launched a Food and Drug Administration review of the mifepristone pill used in two-thirds of abortions across the country.
In a letter to over two dozen Republican attorneys general who requested the FDA review, Kennedy and FDA Commissioner Marty Makary said the agency would conduct “its own review of the evidence, including real-world outcomes and evidence, relating to the safety and efficacy of the drug,” per ABC News.
